Assessing Covid Vaccine Side Effects Among Greater Noida Students: A Retrospective Study On Health Impacts
Abstract
Background
The global COVID-19 pandemic prompted the development of vaccines, with India approving Covishield and Covaxin. Covishield, a viral vector-based vaccine, and Covaxin, an inactivated virus vaccine, underwent rigorous trials. The nationwide vaccination campaign began in January 2021, initially targeting healthcare workers before expanding. Both vaccines have shown efficacy in preventing COVID-19, with stringent monitoring ensuring safety
Meterial and method: A pilot study of purposive sampling among 40 students to confirm the feasibility and acceptability of the study. Data were collected using demographic profile, likert scale questionnaire, based on objective hypothesis to be treated using frequency comparative & inferential statistics using spss 28.
Results: Majority of participants were below 20 years old (54.0%), predominantly female (61.0%), and enrolled in BSc nursing (67.3%), with most in their first year (69.0%) and having received Covishield (69.0%). Significant associations (p < 0.05) were found between age and gender with various side effects, while comorbidities showed significant associations with some side effects. No significant associations were observed with the number of vaccine doses except for fever in Covaxin recipients.
Conclusion
This study sheds light on the side effects of Covishield and Covaxin vaccinations. Different demographics displayed varying symptom profiles, revealing statistically significant associations with age, gender, number of doses, and co-morbidities. These insights underscore the need to factor in demographic variables for effective vaccination strategies and post-vaccination symptom monitoring to ensure safety and efficacy.
References
2. Ghosh A, Walia S, Rattan R, Kanampalliwar A, Jha A, Aggarwal S, et al. Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India [Internet]. Infectious Diseases (except HIV/AIDS); 2021 Aug [cited 2023 Jul 21]. Available from: http://medrxiv.org/lookup/doi/10.1101/2021.08.16.21261912
3. Aslam MA, Zakar R. Impact of public health interventions on COVID-19 control in Lahore. ijhs. 2023 Mar 27;1574–81.
4. Srivastava N, Rathia SK, Dey C, Shukla A, T P, Singh S, et al. The Assessment of the Spectrum of Preventive Measures Taken by Healthcare Providers During the COVID-19 Pandemic in India: A Survey-Based Study. Cureus [Internet]. 2023 Jun 28 [cited 2023 Jul 21]; Available from: https://www.cureus.com/articles /165981-the-assessment-of-the- spectrum-of-preventive-measures-taken-by-healthcare-providers-during-the-covid-19- pandemic-in-india-a-survey-based-study
5. Kahn R, Janusz CB, Castro MC, Da Rocha Matos A, Domingues C, Ponmattam J, et al. The effectiveness of COVID-19 vaccines in Latin America, 2021: a multicenter regional case–control study. The Lancet Regional Health - Americas. 2023 Apr;20:100474.
6. Stegeman I, Ochodo EA, Guleid F, Holtman GA, Yang B, Davenport C, et al. Routine laboratory testing to determine if a patient has COVID-19. Cochrane Infectious Diseases Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2020 Nov 19 [cited 2023 Jul21];2020(11).Available from: http://doi.wiley.com /10.1002 /14651858.CD013787
7. https://www.yalemedicine.org/news/covid-19-variants-of-concern-omicron.
8. Ng TI, Correia I, Seagal J, DeGoey DA, Schrimpf MR, Hardee DJ, et al. Antiviral Drug Discovery for the Treatment of COVID-19 Infections. Viruses. 2022 May 4;14(5):961.
9. Kumar VM, Pandi-Perumal SR, Trakht I, Thyagarajan SP. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. npj Vaccines. 2021 Apr 21;6(1):60.
10. Babu BK, Reddy AY. Myths and Perception of Management Students and Faculty towards Covaxin and Covishield Vaccines, Vijayawada, Andhra Pradesh. JPRI. 2021 Sep 30;174– 84.
11. Lee YK, Kwon Y, Lim D, Seo SY, Kim EK, Kim SY, et al. COVID-19 vaccine safety profile in Republic of Korea, February 26, 2021 through April 30, 2022. Clin Exp Pediatr [Internet]. 2023 Jun 13 [cited 2023 Jul 17]; Available from: http://ecep.org/journal/view.php?doi=10.3345/cep.2022.00815.
12. Andanigoudar KB, Bant DD, H S, U O. Covid Vaccine Side Effects and Covid Infection after Vaccination- A Cross Sectional Study in Hubballi, Karnataka. Natl J Community Med. 2022 Feb 12;13(1):22–6.
